Center for Scientific Review; Notice of Closed Meetings

This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
There is no table of contents available for this document.
Public Comments
Enhanced Content - Public Comments
This feature is not available for this document.
Regulations.gov Data
Enhanced Content - Regulations.gov Data
Additional information is not currently available for this document.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
27
as of
06/28/2026 at 8:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2026-13093 as it appeared on Public Inspection on
06/26/2026 at 8:45 am.
It was viewed
10
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2026-13093 (91 FR 39109)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Kidney Physiology and Development.
Date:
July 22, 2026.
Time:
9:00 a.m. to 8:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Atul Sahai, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-1198,
sahaia@csr.nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Training: Immunology and Infectious Diseases.
Date:
July 22, 2026.
Time:
10:00 a.m. to 2:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Noton K. Dutta, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-4163,
noton.dutta@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; RFA-DK-26-009: New Investigator Gateway Awards for Collaborative T1D Research.
Date:
July 22, 2026.
Time:
10:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Dawanna James-Holly, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-480-2776,
dawanna.james-holly@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Fellowships: Risk, Prevention and Health Behavior.
Date:
July 23, 2026.
Time:
9:30 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Gianina Ramona Dumitrescu, Ph.D., MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892, 301-594-4617,
ramona.dumitrescu@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required).
Date:
July 23, 2026.
Time:
10:00 a.m. to 5:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Jessica Bellinger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301-827-4466,
bellingerjd@csr.nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Immune Signaling in Neurological Disorders and Infectious Diseases.
Date:
July 23, 2026.
Time:
10:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Iqbal Sayeed, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-8258,
iqbal.sayeed@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Training: Immunology and Infectious Diseases.
Date:
July 23, 2026.
Time:
10:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Thomas F. Conway, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD 20892, 301-594-2948,
chiuc@mail.nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Limited Competition Training Grants for the Clinical and Translational Awards (CTS) Program.
Date:
July 23, 2026.
Time:
10:00 a.m. to 5:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Priya Srinivasan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-496-4045,
priya.srinivasan@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Mind Body and Integrative Health Treatment Approaches.
Date:
July 23-24, 2026.
Time:
10:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Cheryl K. Nordstrom, MPH, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, RM 809-N, Bethesda, MD 20892, 301-594-6226,
cheryl.nordstrom@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; PAR-24-306: Mammalian Models.
Date:
July 23, 2026.
Time:
10:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Susan Lynn Spence, Scientific Review Officer, Center for Scientific Review, National Institute of
( printed page 39110)
Health, 6701 Rockledge Drive, National Cancer Institute, NIH, Bethesda, MD 20892, 301-443-3906
susan.spence@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; RFA-HG-22-001: Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional).
Date:
July 23, 2026.
Time:
10:00 a.m. to 4:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Maryam Rohani, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-451-0987,
maryam.rohani@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Mentored Career Development Award Applications.
Date:
July 23, 2026.
Time:
10:00 a.m. to 4:30 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Srihari Seshadri, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-4738,
srihari.seshadri@nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Review of applications for National Centers for Cryo-Electron Tomography, R24, PAR-26-138.
Date:
July 23, 2026.
Time:
10:00 a.m. to 4:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Lee Warren Slice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-9286,
slicelw@mail.nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Fellowships: Neurosensory Systems.
Date:
July 23, 2026.
Time:
11:00 a.m. to 6:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-1242,
kgt@mail.nih.gov.
Name of Committee:
Center for Scientific Review, Special Emphasis Panel; Topics in Cancer Biology.
Date:
July 23, 2026.
Time:
11:00 a.m. to 5:00 p.m.
Agenda:
To review and evaluate grant applications.
Address:
National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format:
Virtual Meeting.
Contact Person:
Sandip Bhattacharyya, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-7121
sandip.bhattacharyya@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: June 25, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.